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ABSTRACT 
To investigate attentional biases in drug addiction, the Emotional Blink of Attention 
paradigm was used to study opioid-dependent patients undergoing inpatient withdrawal 
treatment at the Vanderbilt Psychiatric Hospital. In multiple trials, participants identified a target 
photo which appeared in an RSVP stream 200 or 800 msec after an erotic, neutral, or opioid-
related (pill) distractor photo. Patients generally performed worse at the task than controls, which 
may reflect cognitive impairment from withdrawal symptoms. Patients exhibited an attentional 
blink after the presentation of pill distractors which, although greater than that shown by controls, 
was not differentially greater relative to their overall poorer performance.  Task accuracy for pill 
distractors at lag 2 was modulated by the implementation of treatment in patients, whereas 
accuracy remained consistent across time in controls. Interestingly, task accuracy for pill 
distractors at lag 8 did not improve in patients, which may suggest prolonged problems 
disengaging from drug stimuli even after treatment.  
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INTRODUCTION 
Approximately 15.6% (29 million) of the adult population in the United States will 
engage in illicit drug use at some point in their lives, and approximately 2.9% (5.4 million) 
become addicted to these illicit drugs (Grant & Dawson, 1998; Grant, Dawson, Stinson, Chou, 
Dufour, & Pickering, 2004). Those that seek addiction treatment, or otherwise try to discontinue 
their drug use, are faced with a major challenge—the likelihood of relapse. To understand drug 
relapse, one must understand the neurobiological and cognitive mechanisms underlying drug 
addiction. A direct causal effect becomes evident, in which addiction sets the stage for future 
relapse through significant long-term changes that occur in the brain. 
  Due to its role in motivation and reward, the dopamine system is strongly implicated in 
addiction (Koob & Volkow, 2009). Neuroplasticity from addiction begins with changes in the 
ventral tegmental area (the site of dopamine production), which leads to a cascade of 
neuroadaptations from the ventral striatum to dorsal striatum and orbitofrontal cortex and results 
in dysregulation of the prefrontal cortex, cingulate gyrus, and extended amygdala. One can 
deduce the overall impact of addiction from the sheer number of neural structures involved. In 
fact, it is the persistence of these altered structures that make addicts vulnerable to relapse, 
according to Robinson and Berridge (2000). Their incentive-sensitization theory of addiction 
proposes that addictive drugs produce long-lasting changes in the brain through dopamine, 
particularly in brain systems involved in motivation and reward. The neuroadaptations that take 
place render these brain systems hypersensitive to drugs and drug-related stimuli, and produce 
symptoms of “drug-wanting” (craving) that lead to drug-seeking and drug-taking behavior. 
 Garavan and Hester (2007) describe the cognitive processes that contribute to a person’s 
drug-seeking behavior. A wide spectrum of processes may become dysfunctional and exacerbate 
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a person’s dependence on drugs.  These processes include Pavlovian and instrumental 
reinforcement, attentional processing of environmental stimuli, reward motivation in decision-
making, learning and memory, and the monitoring and inhibiting of one’s behavior. Accordingly, 
cocaine addicts show attentional biases towards drug-related stimuli, poor performance in tests 
of inhibitory control, and compromised monitoring and evaluation of behavior. Out of the 
cognitive processes underlying addiction, this study focuses on attentional bias towards drug-
related stimuli, as assessed by the Emotional Blink of Attention (EBA) paradigm. According to 
Franken, Booij, and van den Brink (2005), attentional bias towards drug cues may contribute to 
addictive behavior in several ways. First, enhanced perception of drug stimuli can result in 
feelings of craving that trigger drug use. Second, once a drug cue is detected, it is more difficult 
to disengage attention away from it, which may further perpetuate drug use. Lastly, the 
automatic focusing on drug cues overcomes competing stimuli that could lead to alternative non-
drug-taking behavior.  
The EBA paradigm has emerged from decades of research on rapid serial visual 
presentation (RSVP) streams, in which stimuli such as letters, words, and pictures are presented 
in rapid succession in the same spatial location. Raymond, Shapiro, and Arnell (1992) first 
coined the term “attentional blink” in their paper on the temporary suppression of visual 
processing. In one of their four experiments, RSVP streams of letters were presented; all of the 
letters were black except for one white letter (Target 1, or T1). Participants were either asked to 
identify the white letter and indicate whether they saw a black X (Target 2, or T2) presented after 
the white letter, or to ignore the color of the white letter and solely indicate whether they saw the 
black X. Task accuracy significantly dropped when participants also had to identify the white 
letter, when the black X was presented 180-450 msec after the white letter. Raymond et al. (1992) 
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attributed the decrease in performance to the allocation of attention in processing T1 (the white 
letter) so much so that there were no resources left to process T2 (the black X) in this time 
span—a phenomenon they called the attentional blink. 
Introduced by Most, Chun, Widders, and Zald (2005), the EBA task incorporates photos 
instead of letters in its RSVP streams. T1 is replaced with an emotional photo, which contrasts 
with neutral photos in the rest of the stream and serves as a critical distractor in finding T2, a 
rotated neutral photo. Most et al. (2005) presented this task to participants in order to investigate 
the degree to which emotional stimuli attract attention at the cost of processing other stimuli. 
Participants were asked to identify the rotated photo among a rapid stream of 17 upright photos, 
each presented for 100 msec. They had to specify whether this target was rotated 90º to the left 
or to the right. All photos in the stream, including the rotated photo, were pictures of landscapes 
or buildings—with the exception of the distractor photo. The distractor was a neutral, scrambled-
negative, or emotionally negative photo shown either two or eight items before the rotated photo 
(lag 2 and lag 8, respectively). Emotionally negative photos included photos of violence, distress, 
and medical trauma in people or animals. Most et al. (2005) found that participants had 
significant difficulty detecting the direction the target was rotated if the distractor was a negative 
photo shown at lag 2. Task accuracy was not affected for the neutral and scrambled-negative 
distractors at lag 2, nor was it affected for presentations of any distractor type at lag 8. 
Attentional biases to negative photos resulted in a temporary inability to process targets that 
participants actively searched for; they experienced an attentional blink after the presentation of 
negative stimuli. 
Furthermore, Most et al. (2005) hypothesized that individual differences related to trait 
anxiety would affect the extent to which a person would be able to reduce his or her attentional 
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blink. To test their hypothesis, they took the highest scorers and lowest scorers on the harm 
avoidance section of the Tridimensional Personality Questionnaire. Low harm avoidance scores 
corresponded to carefree and confident personalities, while high harm avoidance scores 
corresponded to anxious and tense personalities. Though a significant correlation was not found 
between harm avoidance and the magnitudes of attentional blinks in this experiment, a 
subsequent experiment did reveal a correlation. In the second experiment, a specific attentional 
set was introduced; participants were informed that the target photo would be of a building. In 
the nonspecific attentional set, participants were informed that the target photo could be a 
building or a landscape without a building. The specific attentional set helped participants ignore 
the negative distractors and find the target photo, and as a result, individual differences of harm 
avoidance were brought to the surface. Indeed, people who scored lower in harm avoidance did 
significantly better at reducing the magnitudes of their attentional blinks than people who scored 
higher in harm avoidance did. 
The same EBA task has been utilized to test aversively-conditioned stimuli as well. In 
another study, Smith, Most, Newsome, and Zald (2006) found that participants displayed an 
attentional bias to aversively-conditioned photos even when the associations were only recently 
learned. Half of the participants were conditioned against car photos when the car photos were 
paired with an unpleasant noise, while the other half of the participants were conditioned against 
bird photos when the bird photos were paired with unpleasant noise. Photos of cars and birds 
were then used as distractors in the EBA task. Participants were less likely to identify the target 
photo after presentation of the distractor they were aversively conditioned against. The 
aversively-conditioned stimuli were able to cause participants to exhibit an attentional blink.  
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The EBA paradigm is by no means limited to negative stimuli, as positive stimuli have 
also elicited an attentional blink, as discovered in a study by Most, Smith, Cooter, Levy, and 
Zald (2007). Male and female participants were allowed to adopt a specific attentional set, 
similar to the procedure in the 2005 study involving negative stimuli. Erotic photos (of couples 
engaging in sexual activity) and negative photos were used as distractors. Under the specific 
attentional set, men and women had improved accuracy identifying target photos after negative 
distractors but not after erotic distractors. While attending to both erotic and aversive stimuli has 
evolutionary value (for example, in alerting one of a potential mate or potential danger), these 
results point towards the possibility that the two classes of stimuli are processed through 
different cognitive pathways. Emotional effects on attention seem to arise from arousal 
independent of whether something is considered positive or negative, though the effects may in 
fact be stronger for erotic stimuli than other stimulus types, an outcome supported by Arnell, 
Killman, and Fijavz (2007) in their RSVP experiment with various types of emotional words.  
Piech, Pastorino, and Zald (2010) tested the attentional capture of food stimuli using the 
EBA task and found that hunger biases attention towards food stimuli. Participants completed the 
EBA task in two separate sessions, one in which they were hungry and the other in which they 
were sated. In both sessions, they were told that the target photo would always be a landscape. 
Participants performed significantly worse after food distractors in the hungry session than in the 
sated session. However, hunger did not impact task accuracy after presentation of romantic 
distractors; an attentional blink was observed for romantic distractors in both the hungry and 
sated sessions. Piech et al. (2010) demonstrated a unique effect in which participants must be in a 
specific physical state to show an attentional blink towards distractors associated with that state. 
Similar results are anticipated in the present study involving drug-dependent patients. 
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Given that attention is limited in capacity, why are certain stimuli chosen over others to 
occupy our mental resources? After reviewing these EBA experiments, we can begin to answer 
this question. One idea is that potentially dangerous stimuli are given priority because they are 
highly relevant to our survival (Blake, Yang, & Zald, 2007). This was true when the EBA task 
was first conducted with aversive stimuli, though researchers later proved that conditioned 
stimuli, erotic stimuli, and food stimuli also had preferential access to attention (Most, 2006; 
Smith, 2007; Piech, 2010). To be fully inclusive of these, it is best to modify the previous 
statement and say that people are more sensitive to and preoccupied with stimuli in their 
environment that represent their psychological concerns (Rosenberg, 2009). The variety of 
stimuli used in the EBA task indicates that the task effectively assesses attention and provides 
useful information about psychological concerns when evaluated closely. 
In the present study, the EBA task was used to examine whether opioid-related stimuli 
elicit an attentional blink in opioid-dependent patients undergoing inpatient withdrawal treatment 
at the Vanderbilt Psychiatric Hospital. Opioids refer to the class of drugs derived from the opium 
plant and include codeine, oxycodone, hydrocodone, morphine, and heroin. Most of these drugs 
are μ receptor agonists and, upon μ receptor activation, produce an intense euphoric sensation 
followed by a longer-lasting high. Though effective for the treatment of pain, opioids are highly 
addictive. Opioid-dependent users are those who are unable to stop using opioids even in the face 
of difficulties that are caused by the opiate use itself. The 2006 National Survey on Drug Use and 
Health (NSDUH) revealed that, between 1999 and 2006, the number of people illicitly using 
prescription pain relievers doubled from 2.2 million to 5.2 million. In fact, the abundance and 
frequency of opioid use is one reason we chose to test opioid-dependent patients. The other 
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reason is that the opioid-dependent patients follow a very discrete protocol at the Vanderbilt 
Psychiatric Hospital, known as the Clinical Opiate Withdrawal Symptom (COWS) protocol. 
Under the COWS protocol, Clonidine is first administered and is followed by 
Buprenorphine if a patient’s withdrawal symptoms persist. Withdrawal symptoms include: 
anxiety, depression, nausea, diarrhea, and leg and abdominal cramps, as well as strong drug 
cravings. This method of opioid detoxification is known as short-term substitution therapy, in 
which the physician prescribes these substitute medications for opioids and gradually tapers the 
dosage down during a time span of one to two weeks. According to Schatzberg and Nemeroff 
(2004), Buprenorphine works by acting as a partial agonist of the μ opiate receptor and is a 
clinically effective analgesic agent with an estimated potency of 25-40 times that of morphine (p. 
1018). However, due to Buprenorphine’s potential addictive effects, many physicians first 
administer or exclusively rely on Clonidine, an α-adrenergic agonist that inhibits norepinephrine 
release by engaging inhibitory autoreceptors in the locus coeruleus (p. 1015).  
The inhibition of the locus coeruleus by Clonidine is particularly interesting, since this 
brain structure is hypothesized to be the source of the attentional blink (Nieuwenhuis, Gilzenrat, 
Holmes, & Cohen, 2005). According to Aston-Jones and Cohen (2005), the locus coeruleus 
operates in context of two different modes of activity—the phasic and tonic modes. In the phasic 
mode, a task-oriented event produces a widespread but temporally specific release of 
norepinephrine, enhancing processing of motivationally relevant stimuli. In the tonic mode, 
neurons in the locus coeruleus fail to respond phasically to task events due to postactivation 
inhibition. The locus coeruleus is unavailable to process the information for a brief period of 
about 500 msec; it is during this time that an attentional blink occurs (Nieuwenhuis et al., 2005). 
It is fitting that brain regions involved in attentional processing, such as the parietal cortex, 
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pulvinar nucleus, and superior colliculus, receive particularly dense innervation from the locus 
coeruleus (Foote & Morrison, 1987). Moreover, Aston-Jones and Cohen (2005) propose that the 
norepinephrine system helps to regulate the reinforcement learning mechanisms implemented by 
the dopamine system. Disturbances of the two systems are implicated in many psychiatric 
disorders, including drug addiction (Weinshenker & Schroeder, 2007).  
The amygdala can enhance processing of motivationally salient cues and direct attention 
towards emotional stimuli, as observed in a study by Anderson and Phelps (2001). In a task 
involving RSVP streams of neutral words in black color, participants were asked to identify two 
green words that serve as T1 and T2. Healthy participants showed a decreased attentional blink 
towards T1 if T2 was a negative word. In contrast, participants with bilateral damage to the 
amygdala or unilateral lesions to the left amygdala did not show enhanced processing of negative 
words in the task. It suggests that the function of the left amygdala is necessary for breaking 
through an attentional blink caused by the neutral target at T1. A subsequent study by Piech et al. 
(2011) revealed that participants with unilateral damage to the amygdala on either side 
performed no differently than healthy controls in an EBA task involving neutral, aversive, and 
erotic distractors. All participants regardless of amygdala damage exhibited attentional blinks 
after the presentation of aversive and erotic distractors. Thus, the amygdala may not always be 
critical for the emotional modulation of attention, and its role in the EBA paradigm needs to be 
further investigated. Researchers have begun to study other structures such as the anterior 
cingulate, insula, and orbitofrontal cortices and how they may contribute to the EBA (Schwabe et 
al., 2011). 
Field, Munafo, and Franken (2009) conclude that there is a modest but statistically 
significant correlation between subjective craving and attentional bias in cognitive science 
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experiments. Their analysis suggests a combination of conditions that are expected to induce a 
larger correlation between craving and attentional bias: studying users of illicit drugs, using 
direct rather than indirect measures to infer attentional processing, and studying individuals 
whose current level of craving is high rather than low. The design of my experiment fits two out 
of three of the preceding criteria, since opioids are illicit drugs when not prescribed, and patients 
who have not yet received withdrawal treatment should have high craving levels. Direct 
measures of attentional bias involve eye movement monitoring and the measurement of event 
related potentials; indirect measures involve assessing task performance. Though the EBA task 
falls into the latter category, its employment across a diverse range of stimuli has produced 
consistent results. Additionally, the EBA task stands out from previous studies that primarily use 
reaction times as a measure of attentional bias, through demonstrating that stimuli can capture 
attention to the extent of not even perceiving subsequent stimuli. At the very least, results from 
tasks assessing implicit cognitive biases, such as the EBA task, should have better predictive 
utility than those from self-report methods of introspection (McCusker, 2001). 
Though the EBA paradigm has begun to be employed in clinical settings involving 
patients with generalized anxiety disorder and obsessive-compulsive disorder (Olatunji, 
Ciesielski, Armstrong, Zhao, & Zald, 2011; Olatunji, Ciesielski, & Zald, 2011), no published 
studies to date have used the paradigm to study drug-dependent patients undergoing withdrawal 
treatment. The present project serves as a pilot study in addressing the feasibility of performing 
cognitive science research in the addictions unit at the Vanderbilt Psychiatric Hospital. We 
investigated the following questions: 1) Do opioid-dependent patients exhibit an attentional blink 
towards opioid-related stimuli that healthy participants do not exhibit?  2) When patients 
complete the EBA task at each stage of withdrawal treatment, do Clonidine and Buprenorphine 
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modulate the levels of attentional bias towards the opioid stimuli? 3) Finally, do patients’ 
subjective ratings of craving and pain correlate with their level of withdrawal symptoms 
throughout treatment? We hypothesized that: opioid-dependent patients would exhibit an 
attentional blink towards the opioid stimuli whereas healthy participants would not, and the 
magnitude of the blink would decrease through the course of treatment with Clonidine and 
Buprenorphine, along with a decrease in craving and pain ratings and withdrawal symptoms.  
METHOD 
Participants 
Eight patients undergoing inpatient opioid withdrawal treatment at the Vanderbilt 
Psychiatric Hospital participated, as well as eight healthy people matched in age, gender, and 
education who served as controls. The majority of participants were female—five patients and 
five controls. Patients ranged from ages 20 to 38, and controls ranged from ages 18 to 46. 
Patients had between 9 and 15 years of education, and controls had between 11 and 16 years of 
education. Patients received a diagnosis of opioid dependence upon their psychiatric admission 
evaluation. All patients were dependent on opioids in pill form, which included Lortab, Percocet, 
and Oxycontin. 
Symptom Assessment 
Patients were assessed by nurses using the Clinical Opiate Withdrawal Symptom (COWS) 
protocol to determine the need for treatment with Clonidine and Buprenorphine (Wesson & Ling, 
2003). They were given a score of 0 to 4 for the following seven criteria: resting pulse rate, 
sweating over 30 minutes, bone or joint aches, runny nose or tearing, tremor, yawning, and 
anxiety or irritability. They were given a score of 0 to 5 for the following four criteria: 
restlessness, pupil size, gastrointestinal upset, and gooseflesh skin. The maximum score possible 
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was 48. For a score of 5 or greater, 0.1 mg of Clonidine was administered every hour, for up to 
0.4 mg in a span of 8 hours. If a patient received 0.4 mg of Clonidine in 8 hours or scored a 15 or 
greater on COWS prior to receiving 0.4 mg of Clonidine in 8 hours, Buprenorphine injections 
were administered on a rigid schedule of 0.3 mg per dose every 8 hours for 9 consecutive doses. 
Clonidine continued to be administered for scores 5 or greater, for up to 0.4 mg within an 8 hour 
period. Vital signs and COWS scores were obtained prior to each dose of Clonidine and 
Buprenorphine. 
Stimuli 
Stimuli were color photographs—256 upright landscape/architectural, 84 target (42 
landscape/architectural photos rotated 90 degrees to the left or right), 30 neutral, 30 erotic, 30 
opioid-related (photos of pills)—presented on a Dell desktop with a 38.5x31cm display and 
measuring 320 by 240 pixels. The neutral, erotic, and pill photos were used as distractors. 
Neutral photos, of flowers and rocks, were taken from the International Affective Picture System 
(IAPS; Lang, Bradley, & Cuthbert, 2001). Erotic photos, of couples engaging in sexual activity, 
were taken from photos used in previous studies by our lab. Pill photos were taken from the 
Internet. Pill photos were chosen instead of injection and smoking photos because it is the most 
common route of opioid administration among patients at the psychiatric hospital. 
Design 
Primary task 
Patients were tested at three stages in their withdrawal treatment: before receiving 
Clonidine and Buprenorphine, during Clonidine and Buprenorphine (usually after the fourth or 
fifth Buprenorphine injection), and after Clonidine and Buprenorphine (at least 12 hours after 
receiving the last Clonidine and Buprenorphine). The healthy controls were also tested three 
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times on a similar schedule to control for practice effects. These three testings correspond to 
Session 1, Session 2, and Session 3.  
At each session, participants completed trials of an RSVP stream of 17 photos, each 
presented for 100 msec. All photos were upright landscape/architectural photos except for two 
(see Figure 1). One photo was the target, of a landscape rotated 90 degrees to the left or right. 
One photo was the critical distractor, which was a neutral, erotic, or pill photo. The distractor 
photo was positioned as either the 4
th
, 5
th
, 6
th
, 7
th
, or 8
th
 photo within the stream and was 
followed by the target photo two positions later, or the distractor photo was positioned as either 
the 3
rd
, 4
th
, 5
th
, or 6
th
 photo within the stream and was followed by the target photo eight 
positions later (lag 2 and lag 8, respectively). The computer randomized which photos are paired 
with which lag and also randomized the order of trials.  
Participants were asked if they saw a rotated photo and, if they did, to specify which 
direction it was rotated. Both answers had to be correct to count towards our measure of task 
accuracy. They were also told: 1) the rotated photo will always be of a landscape, 2) photos of 
other objects may appear but should be ignored, and 3) not all trials will contain a rotated photo. 
Participants completed an 8-trial practice session (with photos shown at 150 msec and without 
erotic and pill distractors), followed by 76 “real” trials (with photos shown at 100 msec and with 
all three types of distractors). Six of these trials were catch trials, which did not contain a target 
photo. Lastly, participants rated their current drug craving and pain level from a scale of 1 to 7, 
corresponding to “Not at All” through “Most Imaginable.” 
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Rating task 
After completing the primary task, participants rated how positive or negative they found 
the erotic and pill photos, on a scale of 1 to 5. Each photo was shown briefly for 100 msec and 
presented in random order. This rating task was completed only once, at the final testing. 
RESULTS 
Participant Characteristics 
Out of the eight patients tested in this study, six patients experienced severe enough 
withdrawal symptoms to receive Buprenorphine shots. At the beginning of treatment, they 
received COWS scores ranging from 0 to 13 and then each progressed to a score of 15 or greater 
(up to a score of 25). Two patients received only Clonidine and did not advance to the 
Buprenorphine shots. Even though they experienced milder withdrawal, these two patients still 
showed symptom improvement because their COWS scores were higher at the beginning of 
treatment (scores of 8 and 9) than at the end of treatment (scores of 4 and 5). They are included 
in the analyses for this reason. It should be noted that seven out of the eight patients were tested 
for Session 1 in the middle of withdrawal treatment for benzodiazepines. Shown in Table 1, 
opioid-dependent patients and healthy controls were well-matched on gender, age, and education 
level with no significant differences between the two groups (Ps>.05). 
RSVP Task Accuracy 
Means and standard deviations of task accuracy for all conditions 
 Means and standard deviations of task accuracy on the RSVP by distractor, lag, and 
session are presented for patients and controls in Table 2. It should be noted that two patients 
could not be tested for Session 3, and their matched controls were not tested for Session 3 either. 
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The means for patients and controls in Sessions 1 and 2 come from a sample size of eight, while 
the means for patients and controls in Session 3 come from a sample size of six. 
Patient and control accuracy at Session 1 
 To examine whether patients (N=8) and controls (N=8) perform at the task differently, a 2 
(Group: patients, controls) x 3 (Distractor: erotic, neutral, pill) x 2 (Lag: 2, 8) mixed model 
Analysis of Variance (ANOVA) was performed for task accuracy at Session 1. This ANOVA 
included one between-subjects factor of Group and two repeated-measures factors of Distractor 
and Lag. The ANOVA revealed a significant main effect of Group [F(1,14) = 18.40, P=.001, 
partial η2 = .57], reflecting higher accuracy for controls relative to patients, Distractor [F(2,28) = 
39.55, P=.000, partial η2 = .74], reflecting differential performance across distractor types, and 
Lag [F(1,14) = 119.92, P=.000, partial η2 = .90], reflecting higher accuracy at lag 8 than at lag 2. 
These main effects were qualified by a significant Distractor x Lag interaction [F(2,28) = 11.09, 
P=.000, partial η2 = .44]. 
Paired t-tests showed similar significant effects in patient and control accuracy at Session 
1. For patients, task accuracy was significantly higher at lag 8 than at lag 2 after presentation of 
erotic [t(7) = -4.66, P=.002] and pill distractors [t(7) = -5.53, P=.001] but not after neutral 
distractors [t(7) = -1.55, P=.164], indicating an attentional blink towards erotic and pill 
distractors. At lag 2, patients performed significantly better after neutral distractors than after pill 
distractors [t(7) = 2.53, P=.039], after neutral distractors than after erotic distractors [t(7) = -4.28, 
P=.004], and after pill distractors than after erotic distractors [t(7) = -3.25, P=.014]. At lag 8, 
patients performed significantly better after neutral distractors than after erotic distractors [t(7) = 
-3.00, P=.020]. All other comparisons of task accuracy at different lags and distractors were not 
significant (Ps>.05). Controls showed similar effects in Session 1: they exhibited an attentional 
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blink towards erotic and pill distractors, with the highest performance at lag 2 after presentation 
of neutral distractors, followed by performance after presentation of pill distractors, and the 
lowest performance after presentation of erotic distractors (Ps<.05). Furthermore, the lack of a 
significant Group x Distractor interaction signifies that the attentional blinks experienced by the 
two groups were not significantly different in magnitude for either type of distractor. In contrast 
to patients, controls did not perform significantly better after neutral distractors than after erotic 
distractors at lag 8 [t(7) = -1.43, P=.195].  
Independent sample t-tests revealed that patients performed significantly worse than 
controls at the task for erotic distractors at lag 8 [t(14) = -2.65, P=.019], for neutral distractors at 
lag 2 [t(14) = -2.52, P=.025], and for pill distractors both at lag 2 [t(8.88) = -4.35, P=.002] and at 
lag 8 [t(14) = -2.50, P=.026]. These data indicate that, while patients and controls both exhibit 
attentional blinks towards erotic and pill distractors and also have similar differential 
performance for the three distractor types, patients generally perform worse than controls at the 
task—significantly so for erotic distractors at lag 8, neutral distractors at lag 2, and pill 
distractors at both lags. The results for patients are depicted in Figure 2, and the results for 
controls are depicted in Figure 3.  
Patient and control accuracy at Session 1 and Session 2 
To investigate whether the attentional blink changes when treatment is implemented, task 
accuracy of patients (N=8) and controls (N=8) was compared at Sessions 1 and 2. A 2 (Group: 
patients, controls) x 2 (Session: Session 1, Session 2) x 3 (Distractor: erotic, neutral, pill) x 2 
(Lag: 2, 8) mixed model ANOVA was performed for task accuracy. This ANOVA included one 
between-subjects factor of Group and three repeated-measures factors of Session, Distractor, and 
Lag. The ANOVA revealed a significant main effect of Group [F(1,14) = 11.30, P=.005, partial 
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η2 = .48], reflecting higher accuracy for controls relative to patients, Session [F(1,14) = 18.68, 
P=.001, partial η2 = .57], reflecting overall better performance during Session 2, Distractor 
[F(2,28) = 50.42, P=.000, partial η2 = .78], reflecting differential performance across distractor 
types, and Lag [F(1,14) = 144.00, P=.000, partial η2 = .91], reflecting higher accuracy at Lag 8 
than at Lag 2. These main effects were qualified by significant Session x Distractor [F(2,28) = 
5.56, P=.009, partial η2 = .28] and Distractor x Lag [F(2,28) = 20.33, P=.000, partial η2 = .59] 
interactions. 
To examine the significant effects in patients more closely, a 2 (Session: Session 1, 
Session 2) x 3 (Distractor: erotic, neutral, pill) x 2 (Lag: 2, 8) repeated measures ANOVA was 
performed separately for task accuracy in patients and controls. Similar to the mixed model 
ANOVA, the ANOVA for patients revealed significant main effects for Distractor [F(2,14) = 
25.30, P=.000, partial η2 = .78] and Lag [F(1,7) = 58.45, P=.000, partial η2 = .89], as well as a 
significant Distractor x Lag interaction [F(2,14) = 5.27, P=.020, partial η2 = .43]. Likewise, the 
ANOVA for controls showed significant main effects for Distractor [F(2,14) = 25.32, P=.000, 
partial η2 = .78] and Lag [F(1,7) = 96.44, P=.000, partial η2 = .93], and a significant Distractor x 
Lag interaction [F(2,14) = 20.27, P=.000, partial η2 = .74]. However, only the ANOVA for 
patients revealed a significant main effect of Session [F(1,7) = 20.02, P=.003, partial η2 = .74] 
and a Session x Distractor interaction that trended towards significance [F(2,14) =3.29, P=.068, 
partial η2 = .32], which suggests that the significant main effect of Session and the significant 
Session x Distractor interaction in the mixed model ANOVA were driven by patient accuracy.  
Paired t-tests showed identical significant effects in patient and control accuracy at 
Session 2. Similar to Session 1, task accuracy for patients was higher at lag 8 than at lag 2 after 
presentation of erotic [t(7) = -5.29, P=.001] and pill distractors [t(7) = -5.09, P=.001] but not 
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after neutral distractors [t(7) = -.22, P=.834], indicating an attentional blink towards erotic and 
pill distractors. At lag 2, patients performed significantly better after neutral distractors than after 
pill distractors [t(7) = 6.95, P=.000] and also performed significantly better after neutral 
distractors than after erotic distractors [t(7) = -5.46, P=.001]. Unlike Session 1, task accuracy at 
lag 2 was not significantly higher after pill distractors than after erotic distractors [t(7) = -1.24, 
P=.255]. Also unlike Session 1, task accuracy at lag 8 was not significantly higher after neutral 
distractors than after erotic distractors [t(7) = -.08, P=.941]. No comparisons of task accuracy at 
lag 8, or for any other lags and distractors were significant (Ps>.05). Controls showed identical 
effects in Session 1: they exhibited an attentional blink towards erotic and pill distractors and, at 
lag 2, performed significantly better after neutral distractors than after pill distractors and also 
after neutral distractors than after erotic distractors (Ps<.05). 
As shown in Figure 2 and Figure 3, further analyses revealed that the two groups 
performed differently across the two sessions. Paired sample t-tests showed that patients had 
significant improved task accuracy from Session 1 to Session 2 for erotic distractors presented at 
both lag 2 [t(7) = -2.97, P=.021] and lag 8 [t(7) = -4.51, P=.003]. An improvement in task 
accuracy trended towards significance for pill distractors presented at lag 2 [t(7) = -2.18, P=.066]. 
No other comparisons between Session 1 and Session 2 were significant (Ps>.05). For controls, 
there were no significant differences in task accuracy between the two sessions (Ps>.05), but 
there was a trend towards significant improvement for erotic distractors presented at lag 8 [t(7) = 
-2.28, P=.057]. Independent sample t-tests revealed that, similar to Session 1, patients at Session 
2 performed significantly worse than controls for neutral distractors at lag 2 [t(14) = -3.00, 
P=.010] and pill distractors at lag 8 [t(14) = -2.46, P=.027]. Unlike Session 1, patients no longer 
performed significantly worse for erotic distractors at lag 8 and pill distractors at lag 2 (Ps>.05). 
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These data indicate that, in Session 2, patients more closely matched the task accuracy of 
controls for erotic distractors at lag 8 and for pill distractors at lag 2, because patients improved 
significantly in task accuracy from Session 1 to Session 2 for erotic distractors at lag 8, and 
improvement trended towards significance for pill distractors at lag 2.  
Buprenorphine patient accuracy at Session 1 and Session 2 
 Out of the eight patients in this study, six patients received both Clonidine and 
Buprenorphine while two patients received only Clonidine. An additional repeated measures 
ANOVA was performed for the six patients who advanced to Buprenorphine shots to see if 
excluding the two Clonidine-only patients alter the results. A 2 (Session: Session 1, Session 2) x 
3 (Distractor: erotic, neutral, pill) x 2 (Lag: 2, 8) ANOVA revealed significant main effects of 
Session [F(1,5) = 16.36, P=.010, partial η2 = .77], Distractor [F(2,10) = 23.40, P=.000, partial η2 
= .82], and Lag [F(1,5) = 33.45, P=.002, partial η2 = .87], similar to the main effects in the 
ANOVA performed for all patients. However, unlike the results for all patients, in which there 
was a significant Distractor x Lag interaction and a Session x Distractor interaction trending 
towards significance, there were no significant interactions (Ps>.05) and the Distractor x Lag 
interaction only trended towards significance [F(2,10) = 3.00, P=.096, partial η2 = .38].  
Independent sample t-tests revealed that there were no significant differences (Ps>.05) in 
task accuracy at any lag or distractor combination between Buprenorphine patients and all 
patients, as depicted in Figure 4. Paired t-tests for Buprenorphine patients at Session 1 showed an 
attentional blink for erotic distractors [t(5) = -4.34, P=.007] and pill distractors [t(5) = -4.65, 
P=.006]. At lag 2, Buprenorphine patients performed significantly better after neutral distractors 
than after erotic distractors [t(5) = -3.87, P=.012], and at lag 8, performed significantly better 
after neutral distractors than after erotic distractors [t(5) = -4.11, P=.009]. These significant 
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effects were also found in the t-tests including the Clonidine-only patients. However, in contrast 
to all of the patients, Buprenorphine patients did not perform significantly better after neutral 
distractors than after pill distractors [t(5) = 2.48, P=.056], nor after pill distractors than after 
erotic distractors [t(5) = -2.12, P=.087]; rather, these effects trended towards significance. The 
exact same significant effects were found for Buprenorphine patients and all the patients in 
Session 2. Paired t-tests for Buprenorphine patients at Session 2 revealed an attentional blink for 
erotic [t(5) = -3.91, P=.011] and pill distractors [t(5) = -4.37, P=.007], higher task accuracy at lag 
2 after neutral distractors than after erotic distractors [t(5) = -4.63, P=.006] and after neutral 
distractors than after pill distractors [t(5) = 8.14, P=.000], and no significant effects at lag 8 
(Ps>.05). Lastly, paired t-tests for Buprenorphine patients across the two sessions showed that 
they had improved task accuracy from Session 1 to Session 2 for erotic distractors presented at 
lag 8 [t(5) = -5.93, P=.002], whereas all patients showed significant improvement across sessions 
for erotic distractors at both lag 2 and lag 8. These data indicate that excluding the two 
Clonidine-only patients slightly altered the results in Session 1 but not in Session 2, but the 
differences were not large enough to be considered significant between the two groups.  
Patient accuracy at Session 2 and Session 3 
 To investigate whether the attentional blink changes when treatment has concluded, task 
accuracy of patients was compared at Sessions 2 and 3. A total of six patients were tested for 
Session 3—five of which received both Clonidine and Buprenorphine, while one received only 
Clonidine. A 2 (Session: Session 2, Session 3) x 3 (Distractor: erotic, neutral, pill) x 2 (Lag: 2, 8) 
repeated measures ANOVA  revealed main effects of Distractor [F(2,10) = 9.15, P=.006, partial 
η2 = .65], reflecting differential performance across distractor types, and Lag [F(1,5) = 19.37, 
P=.007, partial η2 = .80], reflecting higher accuracy at Lag 8 than at Lag 2. These main effects 
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were qualified by a significant Distractor x Lag interaction [F(2,10) = 8.92, P=.006, partial η2 
= .64]. Main effects of Distractor and Lag and a Distractor x Lag interaction were also found for 
patient accuracy when comparing Session 1 and Session 2. However, unlike Sessions 1 and 2, 
there was no significant main effect of Session [F(1,5) = .17, P=.699, partial η2 = .033] for task 
accuracy in Session 2 and 3, indicating no significant differences in task accuracy across these 
two sessions. The results for patients are depicted in Figure 2. 
 Paired t-tests revealed similar task accuracy in Session 2 and Session 3, with one key 
difference in attentional blinks. Task accuracy in Session 3 was significantly higher at lag 8 than 
at lag 2 after presentation of pill distractors [t(5) = -4.49, P=.006], but only trended towards 
significance after erotic distractors [t(5) = -2.24, P=.076], and was not significant after neutral 
distractors [t(5) = -.52, P=.625], indicating an attentional blink towards pill distractors only. In 
contrast, patients in the Session 2 exhibited significant blinks towards both erotic and pill 
distractors. Similar to Session 2, patients in Session 3 performed significantly better at lag 2 after 
neutral distractors than after erotic distractors [t(5) = -3.02, P=.029] and after neutral distractors 
than after pill distractors [t(5) = 3.07, P=.028, and they did not show significant differences in 
task accuracy at lag 8 (Ps>.05). Lastly, paired t-tests for patients across Sessions 2 and 3 did not 
show significant differences in task accuracy at any lag or distractor type (Ps>.05), which fits 
accordingly with the lack of a main effect of Session. These data indicate that, from Session 2 to 
Session 3, the attentional blink after pill distractors persisted while the blink after erotic 
distractors only trended towards significance; this difference is likely due to the smaller sample 
size of six patients. 
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Valence Ratings for Distractors in the RSVP Task 
 Means and standard deviations of valence ratings for erotic and pill distractors are 
presented in Table 3. Independent sample t-tests revealed that none of the patient and control 
means were significantly different from each other (Ps>.05).  
DISCUSSION 
This study investigated the extent to which emotional stimuli capture the attention of 
opioid-dependent patients as they progressed through inpatient withdrawal treatment at the 
Vanderbilt Psychiatric Hospital. As hypothesized, patients exhibited an attentional blink in the 
RSVP task after the presentation of pill distractors. However, controls also exhibited an 
attentional blink after pill distractors were presented. Critically, the magnitude of this blink was 
not differentially greater in patients than in controls, as revealed by the lack of a Group x 
Distractor interaction. Thus, task accuracy on the EBA task does not appear to provide a robust 
discriminative measure of bias towards opioid pill cues in the context of opioid addiction.  Had 
only patients shown the attentional blink, the EBA task could have potentially been employed as 
an objective assessment to highlight individual differences and differential responses to 
treatment, and perhaps even predict patients who are most vulnerable to relapse. We did not find 
support for its use in this population. 
Both patients and controls exhibited an attentional blink after presentation of erotic 
distractors, which was more robust than the blink associated with pill distractors across all three 
sessions. The attentional capture of erotic stimuli was so powerful that it exceeded that of pill 
stimuli for opioid-dependent patients. This finding is consistent with the Most et al. (2007) and 
Arnell et al. (2007) studies that show erotic stimuli have a unique advantage in occupying 
attentional resources. On the other hand, the pill distractors may be much more ambiguous 
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stimuli. Given that healthy controls exhibited a blink after the pill distractors, these findings 
indicate that pill stimuli are not clinically selective distractors during the RSVP task. The 
problem does not appear to lie in the image characteristics, as the pill distractors were no higher 
in measures of luminance and contrast than the erotic distractors were. Rather, the pill stimuli 
may not be specific enough to opioid addiction. Many people are familiar with taking pills to 
treat short-term illness or may even take them to manage chronic disease. Interestingly, there was 
no significant difference in the valence ratings of pill distractors between patients and controls; it 
is unclear why both groups rated the pills as slightly negative.  
 Though both patients and controls exhibited a blink after the presentation of erotic and 
pill distractors, the two groups executed the task with different levels of performance. Across all 
three sessions and at both lags, patients generally performed worse at the task in comparison to 
controls. These findings may reflect a generalized attentional control deficit in this clinical 
population, as it did in patients with generalized anxiety disorder in Olatunji et al.’s study (2011), 
who also performed with lower task accuracy at both lags 2 and 8. Additionally, opioid-
dependent patients performed consistently worse than controls after neutral distractors at lag 2; 
patients with generalized anxiety disorder also had impaired task accuracy for neutral distractors. 
However, it is important to take into consideration that the opioid-dependent patients in this 
study were tested as they endured severe withdrawal symptoms, which provides an alternative 
explanation for their impaired task accuracy relative to controls. Patients could have been 
preoccupied with their physical symptoms of withdrawal, drawing their attention away from the 
task, and could have also experienced an overall decrease in their ability to concentrate. It is not 
possible to know how much this factor contributes to task accuracy unless a study is performed 
with opioid-dependent participants in a non-treatment setting.  
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 Since patients and controls exhibited a blink after the presentation of pill distractors that 
was not significantly different in magnitude, it becomes crucial to look at whether patients 
experienced an additional amount of blink over controls—that is, the degree to which the blink 
from patients might exceed the blink from controls. One way to evaluate this is to examine 
patient and control accuracy at lag 2 for the erotic and pill distractors that elicited a blink. In 
Session 1, patients performed significantly worse than controls at the task after pill distractors 
shown at lag 2, but not after erotic distractors shown at lag 2. Although it did not reach a point of 
significance, patients experienced an attentional blink for pill distractors that was greater in 
magnitude than the blink controls experienced. This finding fits well with the hypothesis, 
because patients should be more preoccupied with pill stimuli in their environments given their 
dependence on opioids and their inability to take opioids during their hospitalization.  These data 
leave open the possibility that patients are indeed more sensitive to drug-related distractors, but 
suggest the magnitude of the difference is relatively subtle. A larger sample might allow this 
difference to reach statistical significance, but a differential effect is likely to be relatively 
modest given these initial observations.     
 The finding regarding group differences in the attentional blink towards pills also seems 
to be unique to Session 1. In Session 2, patients no longer performed worse than controls after 
pill distractors shown at lag 2. Furthermore, from Session 1 to Session 2, patients showed 
improvement that trended towards significance for pill distractors at lag 2, and showed 
significant improvement for erotic distractors at lags 2 and 8.  In contrast to patients, controls did 
not show significant improvement at any lag and distractor combination but showed an 
improvement that trended towards significance for erotic distractors at lag 8. The greater number 
of conditions in which patients showed improvement can be attributed to the implementation of 
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withdrawal treatment. It appears that receiving Clonidine and Buprenorphine not only reduced 
the degree of attentional capture that pill distractors at lag 2 had on patients but also reduced the 
degree of attentional capture for erotic distractors at both lags. This supports the notion that 
patients generally performed worse at the task than controls did because patients could not focus 
well as a result of their withdrawal symptoms. Accordingly, these symptoms were most 
exacerbated in Session 1 when they had not yet begun to receive treatment. However, one 
possible confounding factor must be considered closely in this regard.  Seven out of the eight 
patients were tested for Session 1 in the middle of withdrawal treatment for benzodiazepines, 
which takes place before withdrawal treatment for opioids. In benzodiazepine treatment, 
Phenobarbitol is administered hourly until patients become drowsy and eventually fall asleep, 
and the medication could have contributed to decreased cognitive performance at Session 1. 
 While the implementation of treatment modulated the effect of pill distractors at lag 2, it 
did not modulate the effect of pill distractors at lag 8. In both Sessions 1 and 2, patients 
performed significantly worse than controls at the task after pill distractors were presented at lag 
8. Furthermore, patients did not show significant signs of improvement for pill distractors at lag 
8 between the two sessions. Olatunji et al. (2011) described the task impairment at lag 2 as 
reflecting sensitivity to attentional capture, whereas impairment at lag 8 reflects problems with 
the disengagement of attention. In this study, opioid-dependent patients showed worse 
performance for pill distractors at lags 2 and 8, but only the impaired performance at lag 8 
persisted through the course of treatment. This indicates that this clinical population may suffer 
from a prolonged problem in disengaging from pill stimuli, rather than in selectively attending to 
pill stimuli, and that withdrawal treatment does not effectively modulate their disengagement of 
attention.  
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 Excluding the two patients who only received Clonidine from the analyses altered the 
findings in Session 1 but did not alter them enough to the point of significance. In Session 1, the 
patients who went on to Buprenorphine shots did not perform significantly better after pill 
distractors than after erotic distractors at lag 2; rather this effect only trended towards 
significance. The Buprenorphine patients also did not show significant improvement from 
Session 1 to Session 2 for erotic distractors at lag 2 and did not show improvement that trended 
towards significance for pill distractors at lag 2. The lower task accuracy for pill distractors at lag 
2 may highlight the greater severity of withdrawal in these patients before receiving treatment; 
the lack of improvement for erotic and pill distractors at lag 2 may point towards a resistance 
towards the attention-modulating effects of treatment. These findings, again, were not significant 
when comparing the Buprenorphine patients to all patients. Research must be done with 
additional patients to reach conclusive results about these trends. 
 Implementing treatment appears to be the critical factor in decreasing the attentional 
capture of pill distractors in patients, because concluding treatment did not affect patient 
accuracy from Session 2 to Session 3. Patients did not show signs of significant improvement at 
any lag and distractor combination between the two sessions. Interestingly, in Session 3, patients 
only exhibited a significant attentional blink after pill distractors; the blink after erotic distractors 
trended towards significance. This is likely due to the smaller sample size of six patients when 
comparing Sessions 2 and 3, as opposed to the sample size of eight patients when comparing 
Sessions 1 and 2. It was hypothesized that, as they progressed through withdrawal treatment, 
patients would show a steady decline in the magnitude of their blink associated with pill 
distractors. These findings show that this is not the case; rather, patients experienced an initial 
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decrease in their attentional capture from pill stimuli when treatment began, and this decrease did 
not change significantly when treatment concluded.  
 It was also predicted that patients’ subjective ratings of craving and pain would correlate 
with their withdrawal symptoms, but we were unable to test this hypothesis due to the inadequate 
timing of symptom assessment. We had planned on using a patient’s COWS scores as an 
assessment of withdrawal symptoms but failed to realize until after data collection that COWS 
scores were not collected at the time of the three experimental sessions. COWS scores were not 
available for several patients at Session 1, because they had not yet been placed on the COWS 
protocol. COWS scores were not available for several patients at Session 3, because patients 
were no longer being assessed on the protocol after completion of Buprenorphine shots. For a 
few patients at Session 2, the last COWS score was not assessed close enough to the time of 
testing; it was usually several hours beforehand. This issue could be remedied by asking a nurse 
to assess each patient’s score on COWS immediately before the patient completes the RSVP task 
and rates craving and pain levels at each session.  
 This study served as a pilot study in addressing the feasibility of performing cognitive 
science research in the addictions unit at the Vanderbilt Psychiatric Hospital. The main barrier 
we encountered was in patient recruitment. Out of all the patients seeking opioid withdrawal 
treatment at the hospital, we were only able to introduce the study to about half of them. We 
were not able to reach out to the other half in time. Due to severe withdrawal, these patients 
received Clonidine, and sometimes Buprenorphine, within a matter of hours upon admission to 
the hospital, which rendered them ineligible for the study since the first testing must be done 
prior to receiving treatment. Out of the patients who were asked to participate in the study, only 
about half of them agreed to. Many opted not to participate because they were not feeling well, 
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which was not unreasonable given their state of withdrawal. Out of the patients willing to 
participate, about half were mentally unable to perform the RSVP task due to drowsiness from 
withdrawal treatment for benzodiazepines. Indeed, we encountered a high comorbidity rate for 
benzodiazepine and opioid addiction, which is evident in the majority of the patients we were 
able to test. With this logic, we were ultimately only able to recruit a rough estimate of 12.5% of 
the opioid-dependent patients receiving treatment at the psychiatric hospital. 
 Several measures were undertaken in an effort to improve patient recruitment. The most 
effective measure was to obtain remote access to StarPanel, Vanderbilt’s electronic medical 
records system, which allowed for us to check daily for new patients at the addictions unit. The 
other measures involved being notified when potential candidates were admitted. All patients 
admitted to the psychiatric hospital must first go through an initial assessment by a team called 
Respond. The staff at Respond was briefed on the criteria we looked for in patients and asked to 
call us to notify us of candidates. The staff members on the unit, including nurses and mental 
health specialists, were also asked to call us to notify us of candidates. However, both groups of 
staff members only did so intermittently. It was not that they did not want to help, for many of 
them were enthusiastic to; rather, they were just unable to add these responsibilities onto their 
already demanding clinical duties. On top of difficulty with patient recruitment, computer issues 
that interfered with the rapid graphic processing necessary for the RSVP task rendered a year’s 
worth of data unusable. Despite our best efforts, a small sample size remained an extreme 
limitation in this study, and we conclude that it is not feasible to efficiently conduct behavioral 
research at the addictions unit for this reason. 
Our small sample size has two main implications for the interpretations of the results. 
First, a small sample size is unfavorable in detecting between-group differences. We had 
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originally aimed to test a total of 30 patients; the greater statistical power with this larger sample 
would have helped to detect the extent to which patients exhibited a larger attentional blink after 
pill distractors in comparison to controls. Even with the smaller sample size, it is promising to 
already see that patients performed worse than controls for pill distractors at lag 2 in Session 1, 
which signals that patients exhibited a larger blink for pill stimuli before they received treatment. 
Second, a small sample size is not as disadvantageous in detecting within-group effects but may 
overlook effects that eventually become significant with a larger sample. It would be interesting 
to see how an increase in sample size would impact patient accuracy across the three 
experimental sessions. Patients already showed improvement that trended towards significance 
from Session 1 to Session 2 for pill distractors at lag 2; testing additional patients could very well 
push this trend into a level of statistical significance in a more adequately powered sample. 
It is essential for future research to address the difficulty of patient recruitment for studies 
of cognitive science at the Vanderbilt Psychiatric Hospital. One way recruitment could 
substantially be improved is to integrate research protocols with standard protocol at the hospital. 
This has recently been proposed by Dr. David Zald and Dr. Peter Martin, who aim to introduce a 
research assessment program that requires the participation of all patients receiving treatment at 
the addictions unit. The program would provide a thorough and comprehensive assessment of 
behavioral and neurobiological dimensions that may help inform long-term course and treatment 
outcomes for patients who struggle with drug addiction. Along with personality questionnaires, 
neuroimaging scans, and genotyping measures, behavioral tasks such as the EBA task used in 
this study would be included in the assessment. With this task, researchers could continue to use 
the same pill distractors to investigate the additional attentional blink elicited by patients over 
controls.  
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Researchers could also pilot a different set of stimuli in hopes of finding stimuli more 
specific to opioid addiction. With the heightened ability to catch patients before they begin to 
receive treatment, it would be possible to study the effects of injection-related distractors on 
heroin and IV morphine users, who typically receive treatment very quickly after admission to 
the hospital. This subset of opioid-dependent patients would be an ideal population to study, as 
they would surely experience severe withdrawal symptoms, and healthy controls would not have 
as much previous exposure to injection-related stimuli. It would also be possible to recruit 
opioid-dependent patients exclusively and eliminate the confounding factor of benzodiazepine 
dependency. Regardless of which stimuli are ultimately tested, it would be highly informative to 
include a control group of people dependent on opioids who do not wish to seek treatment. This 
control group would help determine whether impaired task accuracy in patients is due to a 
general deficit in attentional control or due to the withdrawal symptoms themselves. 
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Table 1. Demographic information by diagnostic group. 
 Patients Controls 
N 8 8 
N female 5 5 
Age M(SD) 32.38 (9.12) 31.62 (10.11) 
Education in years M(SD) 11.38 (1.85) 13.00 (1.60) 
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Table 2. RSVP task means and standard deviations of accuracy percentage by distractor, lag, and session for patients and controls. 
 Patients Controls 
Lag Erotic M (SD) Neutral M (SD) Pill M (SD) Erotic M (SD) Neutral M (SD) Pill M (SD) 
S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S3 S1 S2 S3 
2 18.75 
(14.58) 
40.63 
(17.61) 
36.67 
(19.66) 
63.75 
(19.96) 
74.38 
(9.80) 
63.33 
(10.33) 
36.88 
(16.02) 
49.06 
(14.94) 
40.00 
(10.95) 
35.00 
(18.52) 
45.63 
(30.41) 
48.33 
(27.14) 
85.00 
(13.09) 
90.00 
(11.02) 
85.00 
(13.78) 
63.13 
(5.94) 
61.56 
(12.46) 
64.17 
(11.14) 
8 55.00 
(20.70) 
75.63 
(18.21) 
61.67 
(23.17) 
77.50 
(7.07) 
76.25 
(20.31) 
70.00 
(29.67) 
72.50 
(15.81) 
75.63 
(10.50) 
81.67 
(21.37) 
78.75 
(14.58) 
89.38 
(14.25) 
91.67 
(11.69) 
87.50 
(18.32) 
88.13 
(11.93) 
95.00 
(8.37) 
90.00 
(11.95) 
89.38 
(11.78) 
90.00 
(12.65) 
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Table 3. Patient and control mean valence ratings for erotic and pill distractors.  
 Patients Controls 
Erotic M(SD) 3.15 (1.12) 3.15 (.38) 
Pill M(SD) 2.03 (.80) 2.54 (.45) 
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Figure Captions 
Figure 1. The trial procedure for the emotional blink of attention paradigm. Note that the distractor consisted of three distinct 
categories (erotic, neutral, and pill) presented at 200 and 800ms lags. 
Figure 2. Task accuracy for patients at Lag 2 and Lag 8 by distractor and session. 
Figure 3. Task accuracy for controls at Lag 2 and Lag 8 by distractor and session. 
Figure 4. Task accuracy for Buprenorphine patients and all patients at Sessions 1 and 2 by distractor and lag. 
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Figure 1. 
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Figure 2.  
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Figure 3.  
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Figure 4. 
 
 
 
